Tonix Pharmaceuticals Holding Corp. (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Tonix Pharmaceuticals Holding Corp. (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tonix Pharmaceuticals Holding Corp. (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Tonix Pharmaceuticals Holding Corp. (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
32 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Tonix Pharmaceuticals Holding Corp. (Tonix), formerly Tamandare Explorations Inc. is a pharmaceutical company that offers drugs and medicines. The company develops pharmaceutical products and treatments for disorders of the central nervous system such as fibromyalgia, post traumatic stress disorder and episodic tension-type headache. Its products include TNX-102 SL and Tonmya. Tonixs TNX-102 SL product is a dose and formulation of cyclobenzaprine and is used for the treatment of fibromyalgia and post-traumatic stress disorder. Its tonmya is a formulation provided as cyclobenzaprine HCl sublingual tablets. It sells its products through a network of distributors across the US.

Tonix Pharmaceuticals Holding Corp. (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals whic

  
Source:
Document ID
GDPH272987D
Country
Industry
Ticker
TNXP=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Tonix Pharmaceuticals Holding Corp., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Tonix Pharmaceuticals Holding Corp., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Tonix Pharmaceuticals Holding Corp., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Tonix Pharmaceuticals Holding Corp., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Tonix Pharmaceuticals Holding Corp., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Tonix Pharmaceuticals Holding Corp., Pharmaceuticals &Healthcare, Deal Details1019
  Venture Financing101
    Tonix Pharma Secures US$0.15 Million In Venture Financing101
  Partnerships111
    Tonix Pharma Enters into Agreement with U.S. Army Medical Materiel Development Activity111
  Equity Offering121
    Tonix Pharma Completes Underwriter s Exercise of Over-Allotment Option of Public Offering of Shares for USD1.5 Million122
    Tonix Pharma Raises USD20.1 Million in Public Offering of Shares142
    Tonix Pharma Raises USD28.7 Million in Public Offering of Shares162
    Tonix Pharma to Raise USD8 Million in Private Placement of Shares182
    Tonix Pharma Completes Public Offering Of Shares For US$43.5 Million202
    Tonix Pharma Completes Public Offering Of Units For US$11.4 Million222
    Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$1 Million242
    Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$2.3 Million261
  Debt Offering271
    Tonix Pharmaceuticals Completes Private Placement Of Notes Due 2013 For US$1 Million271
  Acquisition281
    Tamandare Explorations Acquires TONIX Pharma281
Tonix Pharmaceuticals Holding Corp. - Key Competitors291
Key Employees301
Locations And Subsidiaries311
  Head Office311
  Other Locations &Subsidiaries311
Appendix321
  Methodology321
  About GlobalData321
  Contact Us321
  Disclaimer321

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Tonix Pharmaceuticals Holding Corp. (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tonix-Pharmaceuticals-Holding-Corp-TNXP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6712>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Tonix Pharmaceuticals Holding Corp. (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tonix-Pharmaceuticals-Holding-Corp-TNXP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6712>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research